Dana Investment Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Dana Investment Advisors's ELV Position: Q1 2026 in Review
Dana Investment Advisors increased its Elevance Health (ELV) stake by 20% in Q1 2026, buying an estimated $855K and bringing the position to 15,890 shares worth $4.65M. The position accounts for 0.14% of the portfolio, ranked #180.
Dana Investment Advisors first reported a position in ELV in Q2 2013 and has held it in 22 quarters since. The position peaked at $21.2M in Q1 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Dana Investment Advisors held 15,890 shares of Elevance Health worth $4.65M as of Q1 2026.
- Dana Investment Advisors bought 2,600 Elevance Health shares in Q1 2026, an estimated $855K.
- Elevance Health made up 0.14% of Dana Investment Advisors's portfolio in Q1 2026, its #180 holding.
- Dana Investment Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 22 quarters since.
- Dana Investment Advisors's Elevance Health position peaked at $21.2M in Q1 2023.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Dana Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.